PARP9 knockdown confers protection against chemoresistance and immune escape of breast cancer cells by blocking the PI3K/AKT pathway

PARP9 knockdown confers protection against chemoresistance and immune escape of breast cancer cells by blocking the PI3K/AKT pathway

Introduction This study probes the mechanism of the PARP9/PI3K/AKT/PD-L1 axis in the chemoresistance and immune escape of breast cancer cells. Material and methods The expression of related genes was detected in MCF-7/FUL cells. After MCF-7/FUL cells were treated with sh-PARP9 and/or the PI3K/AKT p...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Tao Hong, Dingxiang Dong, Jun Li, Lin Wang
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Termedia Publishing House 2023-03-01
Σειρά:	Archives of Medical Science
Θέματα:	breast cancer parp9 pi3k/akt pathway pd-l1 chemoresistance immune escape
Διαθέσιμο Online:	https://www.archivesofmedicalscience.com/PARP9-knockdown-confers-protection-against-chemoresistance-and-immune-escape-of-breast,161444,0,2.html

Παρόμοια τεκμήρια

CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway
ανά: Ruijie Zhang, κ.ά.
Έκδοση: (2017-09-01)

INPP4B inhibits glioma cell proliferation and immune escape via inhibition of the PI3K/AKT signaling pathway
ανά: Xiaoming Sun, κ.ά.
Έκδοση: (2022-09-01)

Interstitial brachytherapy combined with PARP inhibitors in the treatment of chemoresistant recurrent epithelial ovarian cancer: A case report
ανά: Yuan Bian, κ.ά.
Έκδοση: (2022-12-01)

Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma
ανά: Keisuke Okuno, κ.ά.
Έκδοση: (2022-09-01)

Akt isoforms differentially provide for chemoresistance in prostate cancer
ανά: Bo Ma, κ.ά.
Έκδοση: (2022-05-01)

ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway
ανά: Hongyu Li, κ.ά.
Έκδοση: (2021-10-01)

Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression
ανά: Junli Deng, κ.ά.
Έκδοση: (2019-06-01)

4′-Demethylpodophyllotoxin functions as a mechanism-driven therapy by targeting the PI3K-AKT pathway in Colorectal cancer
ανά: Jun Liu, κ.ά.
Έκδοση: (2025-01-01)

HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process
ανά: Sijia Ma, κ.ά.
Έκδοση: (2024-02-01)

Tertiary Prevention of Ovarian Cancer After PARP Inhibitor Therapy
ανά: ZANG Rongyu
Έκδοση: (2023-02-01)

Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer
ανά: Lin Wang, κ.ά.
Έκδοση: (2022-09-01)

Regulation of MicroRNA-497-Targeting AKT2 Influences Tumor Growth and Chemoresistance to Cisplatin in Lung Cancer
ανά: Lin Wang, κ.ά.
Έκδοση: (2020-09-01)

Aurora-A Induces Chemoresistance Through Activation of the AKT/mTOR Pathway in Endometrial Cancer
ανά: Jun Wu, κ.ά.
Έκδοση: (2019-05-01)

PARP9 exacerbates apoptosis and neuroinflammation via the PI3K pathway in the thalamus and hippocampus and cognitive decline after cortical infarction
ανά: Mengshi Liao, κ.ά.
Έκδοση: (2025-02-01)

Knockdown of SNORA47 Inhibits the Tumorigenesis of NSCLC via Mediation of PI3K/Akt Signaling Pathway
ανά: Huiqing Yu, κ.ά.
Έκδοση: (2021-03-01)

Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma
ανά: Akshay Pratap, κ.ά.
Έκδοση: (2023-12-01)

Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
ανά: Charles-André Philip, κ.ά.
Έκδοση: (2017-09-01)

Exploring role of 5hmC as potential marker of chemoresistance
ανά: Suhas S. Kharat, κ.ά.
Έκδοση: (2020-11-01)

Uev1A promotes breast cancer cell survival and chemoresistance through the AKT-FOXO1-BIM pathway
ανά: Zhaojia Wu, κ.ά.
Έκδοση: (2019-12-01)

Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer
ανά: Hua Su, κ.ά.
Έκδοση: (2024-03-01)

SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis
ανά: Gao Zhenyuan, κ.ά.
Έκδοση: (2020-10-01)

Depletion of PARP10 inhibits the growth and metastatic potential of oral squamous cell carcinoma
ανά: Zihui Zhou, κ.ά.
Έκδοση: (2022-10-01)

Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K
ανά: Ivan Yudushkin
Έκδοση: (2019-02-01)

Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape
ανά: Xueqin Zou, κ.ά.
Έκδοση: (2021-04-01)

PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages
ανά: Lu Wang, κ.ά.
Έκδοση: (2022-10-01)

Knockdown of CCNB2 inhibits the tumorigenesis of gastric cancer by regulation of the PI3K/Akt pathway
ανά: Ming Hu, κ.ά.
Έκδοση: (2025-02-01)

Evodiamine inhibits programmed cell death ligand 1 expression via the PI3K/AKT signaling pathway to regulate antitumor immunity in melanoma
ανά: Jiamin Li, κ.ά.
Έκδοση: (2025-02-01)

The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
ανά: Liying Ma, κ.ά.
Έκδοση: (2020-10-01)

PI3K/AKT Pathway and Brain Malformations
ανά: Gavin B. Rice, κ.ά.
Έκδοση: (2015-07-01)

Silencing of PARP2 Blocks Autophagic Degradation
ανά: Laura Jankó, κ.ά.
Έκδοση: (2020-02-01)

Prospects for combining immune checkpoint blockade with PARP inhibition
ανά: Anping Li, κ.ά.
Έκδοση: (2019-09-01)

Editorial: New strategies to tackle chemoresistance in cancer
ανά: Carmela De Marco, κ.ά.
Έκδοση: (2022-10-01)

IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway
ανά: Peng Liu, κ.ά.
Έκδοση: (2024-01-01)

The Upregulation of IL-1β Induced by Cisplatin Triggers PI3K/AKT/MMP9 Pathway in Pericytes Mediating the Leakage of the Blood Labyrinth Barrier
ανά: Yu M, κ.ά.
Έκδοση: (2025-01-01)

Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer
ανά: Yang Gao, κ.ά.
Έκδοση: (2021-11-01)

Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells
ανά: Paulina Gil-Kulik, κ.ά.
Έκδοση: (2020-05-01)

Patient Derived Organoids Confirm That PI3K/AKT Signalling Is an Escape Pathway for Radioresistance and a Target for Therapy in Rectal Cancer
ανά: Kasun Wanigasooriya, κ.ά.
Έκδοση: (2022-07-01)

Immune‐independent acquired resistance to PD‐L1 antibody initiated by PD‐L1 upregulation via PI3K/AKT signaling can be reversed by anlotinib
ανά: Yuan Gao, κ.ά.
Έκδοση: (2023-07-01)

Knockdown of RASD1 improves MASLD progression by inhibiting the PI3K/AKT/mTOR pathway
ανά: Guifang Zeng, κ.ά.
Έκδοση: (2024-12-01)

Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K/Akt/mTOR pathway
ανά: Guofei Feng, κ.ά.
Έκδοση: (2023-08-01)